Thomas P. Mathers joined CoLucid Pharmaceuticals, Inc., as Chief Executive Officer in 2011. He has more than 22 years of executive management experience in the life sciences and medical device industry. Mr. Mathers also serves on the board of directors for the Biotechnology Industry Organization — BIO — and as Founder and Chairman of Declion Holdings and its affiliates. Prior to CoLucid, Mr. Mathers served as President and CEO of Peptimmune, Inc.; President and CEO of Cell Based Delivery; Vice President and General Manager of Cardion AG; Vice President of Strategic Development at Genzyme; and management positions at Snowden-Pencer and Pfizer, Inc. He holds several patents and patents pending, and earned his B.S. in engineering from the United States Military Academy at West Point. From 1988 to 1991, he served as captain in the United States Army and was awarded several medals for his services as an AH-64 Apache helicopter pilot in the Gulf War in the XVIII Airborne Corps.
Interview with the CEO and the CFO: CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD)
April 22, 2016